21498 ⎘
Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes; Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
Mapping glutathione deficiency and/or dysfunction of mitochondria
#2SYSTEMS AND METHODS FOR MONITORING OF DELIVERY OF LABEL-FREE DRUGS
#3TARGETED CONTRAST AGENTS FOR MRI OF AMYLOID DEPOSITION
#4LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF
#5LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF
#6ALGINIC ACID-BASED INJECTABLE HYDROGEL SYSTEM
#7LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE,PREPARATION METHOD THEREFOR, AND USES THEREOF
#8TARGETED CONTRAST AGENTS FOR MRI OF ALPHA-SYNUCLEIN DEPOSITION
#9STIMULI - OR BIO- RESPONSIVE COPOLYMERS, THE POLYMERSOMES COMPRISING THE SAME AND THEIR USE IN DRUG DELIVERY
#10Targeted contrast agents for MRI of alpha-synuclein deposition
#11IMAGING WITH LIPOSOME-BASED CONTRAST AGENTS BASED ON MODULATION OF MEMBRANE WATER PERMEABILITY
#12STICKY PARTICLES FOR EFFICIENT IMAGING
#13ULTRAFINE IRON OXIDE NANOPARTICLE-BASED MAGNETIC RESONANCE IMAGING T1 CONTRAST AGENT
#14MRI CONTRAST AGENT FOR USE IN THE DIAGNOSIS OF EARLY CHANGES IN THE ENDOTHELIUM OF BLOOD VESSELS
#15FORMATION AND USES OF EUROPIUM
#16NANOCARRIER SYSTEMS FOR IMAGING AND DELIVERY OF ACTIVE AGENTS
#17TARGETED CONTRAST AGENTS FOR MRI OF AMYLOID DEPOSITION
#18ALGINIC ACID-BASED INJECTABLE HYDROGEL SYSTEM
#19FUSOGENIC LIPOSOMES FOR SELECTIVE IMAGING OF TUMOR CELLS
#20In-case stand for a musical instrument
#21TARGETED CONTRAST AGENTS FOR MRI OF ALPHA-SYNUCLEIN DEPOSITION
#22Targeted contrast agents for MRI of amyloid deposition
#23VITAMIN E DERIVATIVES AND THEIR USE AS MULTI-SCALE IMAGING AGENTS
#24Targeting nanoparticles
#25TARGETED CONTRAST AGENTS FOR MRI OF AMYLOID DEPOSITION
#26TARGETING LIGANDS FOR TAU PATHOLOGY
#27PH and Oxygen dual-sensitive magnetic resonance imaging contrast agent and preparation method thereof
#28MAGNETIC LIPOSOMES AND RELATED TREATMENT AND IMAGING METHODS
#29LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE,PREPARATION METHOD THEREFOR, AND USES THEREOF
#30MRI imaging of amyloid plaque using liposomes
#31MRI IMAGING OF AMYLOID PLAQUE USING LIPOSOMES
#32Formation and uses of europium
#33Conjugated polymer-based nanoprobe and preparation method and application thereof
#34PREPARATION METHOD FOR AND USE OF REDOX-RESPONSIVE CHITOSAN-LIPOSOME
#35Liposomal gadolinium (GD) contrast agent “NMRX” for T1-MRI
#36Fabrication of Magnetic Vesicles for Biomedical Imaging and Delivery
#37MICROFLUIDIC-FORMULATED LEUKOSOME COMPOSITIONS AND FABRICATION METHODS THEREFOR
#38Hybrid membrane-coated nanoparticle composites and methods of making and using the same
#39Stimuli-responsive magneto-plasmonic nanocarrier
#40Nanoparticles
#41Lipid-based drug carriers for rapid penetration through mucus linings
#42Hydrophilic fluorinated molecules for liposomal 19F MRI probes with unique MR signatures
#43ADMINISTRATION OF GROWTH FACTORS FOR THE TREATMENT OF CNS DISORDERS
#44Cathepsin-binding compounds bound to a carrier and their diagnostic use
#45Lipid-based nanoparticles
#46Liposome nanoparticles for tumor magnetic resonance imaging
#47SYSTEMS AND METHODS OF DETECTING INTERSTITIAL CYSTITIS
#48Gadolinium expressed lipid nanoparticles for magnetic resonance imaging
#49MRI imaging of amyloid plaque using liposomes
#50Liposomes useful for drug delivery to the brain
#51SYSTEMS AND METHODS OF DETECTING INTERSTITIAL CYSTITIS
#52MRI imaging of amyloid plaque using liposomes
#53Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles
#54FORMATION AND USES OF EUROPIUM
#55Administration of growth factors for the treatment of CNS disorders
#56Dual mode gadolinium nanoparticle contrast agents
#57MAGNETIC RESONANCE IMAGING AND/OR SPECTROSCOPY CONTRAST AGENTS AND METHODS OF USE THEREOF
#58Chelating amphiphilic polymers
#59Preparation of antibody or an antibody fragment targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
#60LIPOSOME INCLUDING ACTIVE INGREDIENT AND IMAGING AGENT AND USE THEREOF
#61Lipid-based drug carriers for rapid penetration through mucus linings
#62NEUROPHILIC NANOPARTICLES
#63Cathepsin-binding compounds bound to a carrier and their diagnostic use
#64Method of producing a cationic liposomal preparation comprising a lipophilic compound
#65METHOD FOR DIAGNOSING OR TREATING TUMORS USING SPHINGOMYELIN CONTAINING LIPOSOMES
#66Compositions and methods for multimodal imaging
#67TUMOR-TARGETED NANODELIVERY SYSTEMS TO IMPROVE EARLY MRI DETECTION OF CANCER
#68BIOMARKER-TARGETING CONTRAST AGENTS AND THEIR USE IN MAGNETIC RESONANCE IMAGING FOR DETECTION OF ATHEROSCLEROTIC PLAQUE
#69Lipidomimetic compounds and uses thereof
#70Nanoparticles delivery systems, preparation and uses thereof
#71Administration of growth factors for the treatment of CNS disorders
#72Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
#73Methods and compositions for objectively characterizing medical images
#74Novel Liposome Nanoparticles for Tumor Magnetic Resonance Imaging
#75Lipid bilayer carrier for drugs or imaging agents
#76ULTRASOUND-ACTIVATED NANOPARTICLES AS IMAGING AGENTS AND DRUG DELIVERY VEHICLES
#77Lipid-based nanoparticles
#78Methods For Loading Contrast Agents Into A Liposome
#79Method of producing a cationic liposomal preparation comprising a lipophilic compound
#80GADOLINIUM EXPRESSED LIPID NANOPARTICLES FOR MAGNETIC RESONANCE IMAGING
#81Ultrasonically-triggered drug vehicle with magnetic resonance imaging function
#82Aptamer-containing compositions and methods for targeting E-selectin
#83Administration of growth factors for the treatment of CNS disorders
#84Non-invasive detection of complement-mediated inflammation using CR2-targeted nanoparticles
#85Antibody-Targeted Carrier For Contrast Agents
#86ENCAPSULATING SYSTEM FOR CEST IMAGING WITH CHELATE Q GREATER THAN OR EQUAL TO 2
#87Multimodal imaging of atherosclerotic plaque targeted to LOX-1
#88Magnetic resonance imaging and/or spectroscopy contrast agents and methods of use thereof
#89CLUSTERED MAGNETIC PARTICLES AS TRACERS FOR MAGNETIC PARTICLE IMAGING
#90Drug carrier providing MRI contrast enhancement
#91Targeted delivery of imaging probes for in vivo cellular imaging
#92Chelating amphiphilic polymers
#93Method of increasing the bioavailability of recombinant human insulin isophane in a patient
#94COMPOSITIONS AND METHODS FOR PRODUCING EMULSIONS FOR NUCLEAR MAGNETIC RESONANCE TECHNIQUES AND OTHER APPLICATIONS
#95REMOTE DETECTION OF SUBSTANCE DELIVERY TO CELLS
#96KIT FOR DETECTING CANCER CELLS METASTASIZING INTO SENTINEL LYMPH NODE
#97Method of producing a cationic liposomal preparation comprising a lipophilic compound
#98NON-SPHERICAL CONTRAST AGENTS FOR CEST MRI BASED ON BULK MAGNETIC SUSCEPTIBILITY EFFECT
#99POLYMERIC DRUG CARRIER FOR IMAGE-GUIDED DELIVERY
#100MICROCAPSULE AND METHOD FOR MAGNETIC RESONANCE IMAGING TO LOCALIZE BLOOD
#101Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
#102T1 MRI TRACKABLE DRUG DELIVERY PARTICLES, USES AND METHODS THEREOF
#103Ionic and non-ionic radiographic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics
#104Use of metal nanoparticles in the diagnosis of Alzheimer's disease
#105Compositions and Methods for Convection Enhanced Delivery of High Molecular Weight Neurotherapeutics
#106MRI TRACKABLE DRUG DELIVERY PARTICLES, USES AND METHODS THEREOF
#107SELF-ASSEMBLED BIODEGRADABLE POLYMERSOMES
#108USE OF PARTICULATE CONTRAST AGENTS IN DIAGNOSTIC IMAGING FOR STUDYING PHYSIOLOGICAL PARAMATERS
#109MRI CONTRAST MEDIUM CONTAINING LIPOSOMES
#110SUPRAMOLECULAR AGGREGATES CONTAINING CHELATING AGENTS AND BIOACTIVE PEPTIDES AS EFFECTIVE AND SELECTIVE DELIVERY TOOLS FOR DRUGS AND CONTRAST AGENTS IN MRI OR NUCLEAR MEDICINE
#111Linkers for anchoring targeting ligands
#112Higher fatty acid triester compound having diethylenetriamine-type metal chelate structure
#113Liposomes
#114Compositions and method for multimodal imaging
#115Responsive MRI contrast agents
#116Contrast Agents Encapsulating Systems for Cest Imaging
#117COMPOSITIONS AND METHODS FOR CONVECTION ENHANCED DELIVERY OF HIGH MOLECULAR WEIGHT NEUROTHERAPEUTICS
#118Administration of growth factors for the treatment of CNS disorders
#119Methods and compositions for imaging
#120Targeted MR imaging agents
#121Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
#122Methods for identification, diagnosis, and treatment of breast cancer
#123Blood clot-targeted nanoparticles
#124MRI imageable liposomes for the evaluation of treatment efficacy, thermal distribution, and demonstration of dose painting
#125Liposomal assembly for therapeutic and/or diagnostic use
#126Glycerophosphoric acid ester derivative having polyfunctional metal chelate structure
#127Contrast medium comprising liposomes containing hydrophobic chelate compound
#128CONTRAST AGENTS FOR MYOCARDIUM PERFUSION IMAGING
#129Methods to ameliorate and image angioplasty-induced vascular injury
#130Tumor-targeted nanodelivery systems to improve early MRI detection of cancer
#131Liposomes useful for drug delivery to the brain
#132SONO-ACTIVE LIPOSOMES AND LIPID PARTICLES AND USE THEREOF AS CONTRAST AGENTS AND ACTIVE-AGENT DELIVERY SYSTEMS
#133Hepatocyte delivery vehicle for delivery of a combination of recombinant human regular insulin and recombinant human insulin isophane to a mammal
#134Camptothecin-carboxylate formulations
#135Methods and compositions for imaging
#136Non-vesicular cationic lipid formulations
#137Method of producing a cationic liposomal preparation comprising a lipophilic compound
#138Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
#139Use of particulate contrast agents in diagnostic imaging for studying physiological paramaters
#140Ionic and non-ionic radiograhic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics
#141Remote detection of substance delivery to cells